A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis

References

• Leigh PN, Ray-Chaudhuri K. Motor neuron disease. J Neurol Neurosurg Psychiatry. 1994;57:886–96.
   PubMed Web of Science ®Google Scholar
• Hobson EV, McGeachan A, Al-Chalabi A, Chandran S, Crawley F, Dick D, et al. Management of sialorrhoea in motor neuron disease: a survey of current UK practice. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:521–7.
   PubMed Web of Science ®Google Scholar
• Young CA, Ellis C, Johnson J, Sathasivam S, Pih N. Treatment for sialorrhoea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database Syst Rev 2011(5):CD006981. Available at http://onlinelibrary.wiley.com Acessed April 10, 2014.
   Web of Science ®Google Scholar
• Reddihough D, Erasmus CE, Johnson H, McKellar GM, Jongerius PH. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. European Journal of Neurology. 2010;17:109–21
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, England JD, Foreshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioural impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227–33.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2011;19:360–75
   PubMed Web of Science ®Google Scholar
• Squires N, Humberstone M, Wills A, Arthur A. The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neuron disease: a systematic review. Dysphagia. 2014;29:500–8
   PubMed Web of Science ®Google Scholar
• Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, et al. Randomized double-blind study of botulinum toxin type B for sialorrhoea in ALS patients. Muscle Nerve. 2009;39:137–43
   PubMed Web of Science ®Google Scholar
• Rosales RL, Bigalke H, Dressler D. Pharmacology of botulinum toxin: differences between type A preparations. European journal of neurology: the official journal of the European Federation of Neurological Societies 2006;13(Suppl): 2–10.
   Web of Science ®Google Scholar
• Tan E-K. Botulinum toxin treatment of sialorrhoea: comparing different therapeutic preparations. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2006;13 (Suppl 1):60–4.
   PubMed Web of Science ®Google Scholar
• Burgen ASV, Dickens F, Zatman LJ. The action of botulinum toxin on the neuro-muscular junction. The Journal of Physiology. 1949;109:10–24.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Grönberg H, Franzen L, Funegård U. External radiation of the parotid glands significantly reduces drooling in patients with motor neuron disease with bulbar paresis. Journal of the Neurological Sciences. 2001;191:111–14.
   PubMed Web of Science ®Google Scholar
• Guy N, Bourry N, Dallel R, Duale C, Verrelle P, Lapeyre M, et al. Comparison of radiotherapy types in the treatment of sialorrhoea in amyotrophic lateral sclerosis. Journal of Palliative Medicine. 2011;14:391–5.
   PubMed Web of Science ®Google Scholar
• Harriman M, Morrison M, Hay J, Revonta M, Eisen A, Lentle B. Use of radiotherapy for control of sialorrhoea in patients with amyotrophic lateral sclerosis. The Journal Otolaryngology. 2001;30:242–5.
   PubMedGoogle Scholar
• Neppelberg E, Haugen DF, Thorsen L, Tysnes OB. Radiotherapy reduces sialorrhoea in amyotrophic lateral sclerosis. European Journal of Neurology: the official journal of the European Federation of Neurological Societies. 2007;14:1373–7.
   PubMed Web of Science ®Google Scholar
• Martin TJ, Conley SF. Long-term efficacy of intra-oral surgery for sialorrhoea. Otolaryngology: head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2007;137:54–8.
   PubMed Web of Science ®Google Scholar
• Oliveira RS, Resende C, Campos J, Salgado C. Surgical approach to sialorrhoea: a casuistic review and evaluation of grade of satisfaction. Cirugía pediátrica: organo oficial de la Sociedad Española de Cirugía Pediátrica. 2010;23:211–14.
   PubMedGoogle Scholar
• Stamataki S, Behar P, Brodsky L. Surgical management of drooling: clinical and caregiver satisfaction outcomes. International Journal of Pediatric Otorhinolaryngology. 2008;72:1801–5.
   PubMed Web of Science ®Google Scholar
• Banfi P, Ticozzi N, Lax A, Guidugli GA, Nicolini A, Silani V. A Review of Options for Treating Sialorrhoea in Amyotrophic Lateral Sclerosis. Respir Care. 2015;60:446–54.
   PubMed Web of Science ®Google Scholar
• Newall AR, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND. Journal of the Neurological Sciences. 1996;139:43–4.
   PubMed Web of Science ®Google Scholar
• Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhoea: a management challenge. Am Fam Physician. 2004;69:2628–34.
   PubMed Web of Science ®Google Scholar
• Suskind DL, Tilton A. Clinical study of botulinum-toxin in the treatment of sialorrhoea in children with cerebral palsy. Laryngoscope. 2002;112:73–81.
   PubMed Web of Science ®Google Scholar
• McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. Br Med J England. 2008:658–62.
   PubMed Web of Science ®Google Scholar
• Mato A, Limeres J, Tomas I, Munoz M, Abuin C, Feijoo JF, et al. Management of drooling in disabled patients with scopolamine patches. Br J Clin Pharmacol. England. 2010:684–88.
   PubMed Web of Science ®Google Scholar
• Mirakhur RK, Dundee JW. Comparison of the effects of atropine and glycopyrrolate on various end-organs. J R Soc Med. 1980;73:727–30
   PubMed Web of Science ®Google Scholar
• Dressler D, Hallett M. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc. Eur J Neurol. 2006;13 (Suppl 1):11–15.
   PubMed Web of Science ®Google Scholar
• Slade A, Stanic S. Managing excessive saliva with salivary gland irradiation in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2015;352:34–6.
   PubMed Web of Science ®Google Scholar
• Heritier Barras AC, Adler D, Iancu Ferfoglia R, Ricou B, Gasche Y, Leuchter I, et al. Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group. Swiss Med Wkly. 2013;143:13830.
   PubMed Web of Science ®Google Scholar
• Kasarskis EJ, Hodskins J, St Clair WH. Unilateral parotid electron beam radiotherapy as palliative treatment for sialorrhoea in amyotrophic lateral sclerosis. J Neurol Sci. 308:155–7.
   PubMed Web of Science ®Google Scholar